1. 首页
  2. 技术文章
  3. 正文

JCRB细胞库 JCRB0086

JCRB细胞库,正在收集各种人类和动物培养细胞,包括癌症和转基因细胞。细胞资源被分配给日本乃至*的研究人员。这些细胞通过测试微生物污染,病毒污染和交叉培养物污染而获得全面认证。一些细胞的特征是核型分析和/或细胞表面标记。我们与世界上其他主要的细胞库合作,正在开发细胞培养和质量控制方法,以支持药物科学医学的基础研究。

恭喜艾美捷科技cellbank细胞报关,顺利通关!

JCRB细胞库JCRB0086[TALL-1]

接受日期:1986年5月15日
动物:人的
性别和年龄:男:28岁
科学名称:智人智人
病历:急性淋巴细胞白血病
分类:
组织准备:骨髓
肿瘤起源:骨髓
开始细胞培养的日期:05/16/86
细胞的历史:三宅一生=> NIHS(JCRB)
介质:含10%胎牛血清的RPMI1640培养基
通道方法:稀释。
CO2浓度:5%
单元号通过时:5x10 ^ 5细胞/ ml
遗传学:T细胞
寿命:无穷
形态学:淋巴细胞样
特点:T细胞淋巴细胞白血病。模式= 95-101
小区ID数据:可用的
DNA谱(STR):D5S818:9,12
D13S317:8,9
D7S820:10,11
D16S539:9,10
VWA:17,19
TH01:7,9
Amelogenin:X,Y
TPOX:8,11
CSF1PO:11,13
检测到的病毒DNA:CMV(-),EBV(-),HHV6(-),HHV7(-),BKV(-),JCV(-),ADV(-),parvoB19(-),HBV(-),HTLV1(-), HTLV2(-),HIV1(-),HIV2(-),HPV18(nt)[-/阴性,+ /阳性,nt /未测试]-说明
建立者Hiraki,S.
存入者Miyoshi,I.
单元库:NIHS(JCRB)

批号:052386:代币/种子(JCRB0086)]
  • 从库存中繁殖细胞,传代号052386
    P3 *
    细胞培养的开始日期:05/30/86
    安瓿中细胞的浓度:7.5x10 ^ 5细胞/ ml
    显微镜下的存活率(%):98%
    使用的抗生素:免费
    支原体,细菌和真菌的检测结果均为阴性。经测试同工酶,AST,G6PD,LD,MD,MPI,NP,PEPB。







[这批的文化条件。

  • 培养基:含10%胎牛血清的RPMI1640培养基。传代
    方法:稀释。
    生长温度:37
    细胞编号:5x10 ^ 5细胞/ ml
    备注:在安瓿瓶上批号:052386。
    补充说明:冷冻前的生存力为99%。在10/20/87检查生存力。
批号:071286:分销(JCRB0086)]
  • 传代号,P6 *
    细胞培养的开始日期:86/07/12
    细胞浓度:9x10 ^ 5细胞/ ml
    使用的抗生素:免费支原体,细菌和真菌的检测均为阴性。经测试同工酶,AST,G6PD,LD,MD,MPI,NP,PEPB。






[这批的文化条件。

  • 培养基:RPMI1640 + FCS 10%
    通过方法:稀释。
    生长温度:37
    细胞传代数:5x10 ^ 5细胞/毫升
    其他说明:确保安培数足够多。






[附加数据]

    下载日期:2008-06-13)

    [批号:111787:分销(JCRB0086)]
    • 通道号,P5 *
      细胞培养的开始日期:11/17/87
      安瓿中细胞的浓度:2.8x10 ^ 6细胞/ ml
      使用的抗生素:免费支原体,细菌和真菌的检测均为阴性。经测试的同工酶,G6PD,LD,NP。






    [这批的文化条件。

    • 培养基:RPMI1640 + FCS 10%
      通过方法:稀释。
      生长温度:37
      细胞数:5x10 ^ 5细胞/ ml
      附加说明:冷冻前活力为84%。






    [附加数据]

      下载日期:2008-06-13)

      [批号:062994:分销(JCRB0086)]
      • 传代号,P6 *
        开始细胞培养,无需克隆之前的库存。
        开始细胞培养的日期:94/08/94
        安瓿中细胞的浓度:1.02x10 ^ 7细胞/ ml
        生长速率:36.2小时
        显微镜下生存力(%):79.6
        使用的抗生素:免费
        支原体,细菌和真菌的检测负。经测试的同工酶,G6PD(typeB),LDH,NP。锚固依赖性:小区标识:可用







      [这批的文化条件。

      • 培养基:含有10%热灭活胎牛血清的RPMI1640培养基(JR Scientific,CO19407)。传代
        方法:简单稀释法。
        生长温度:37 C传代
        细胞数:1.3x10 ^ 5细胞/ ml






      [附加数据]

      STR-PCR(1),
      • STR-PCR(2),

      下载日期:2008-06-13)



      cellroot.dbfcellspec.dbf导出。

      参考文献

      1.肯塔基州小川市,柴田市,田野清洲,伊野口市,Y。岸田,石本市和安达市。人类免疫缺陷病毒vpr开放阅读框的变异分析,J。Virol。,63:4110-4114,1989。

      • 注意:通过重组DNA技术将突变引入人免疫缺陷病毒1型传染性分子克隆的vpr开放阅读框。在几种人类CD4 +淋巴细胞细胞系中研究了这些变化对从转染细胞中重新整合的病毒的复制和细胞病理学特性的影响。在所有情况下,突变病毒均具有传染性和细胞致病性。但是,当使用低投入剂量时,突变体的生长速度明显快于野生型病毒。vpr突变体的生长动力学不同于vif和vpu突变体。
        参考编号:710

      2.I. Miyoshi,S. Hiraki,T. Tsubota,T. Kubonishi,I. Matsuda,Y.,Nakayama,T. Kishimoto,H.和Kimura,I.源自急性淋巴细胞白血病的人B细胞,T细胞和空细胞白血病细胞系,《自然》,267:843-844,1977。

      • 注意:尽管已经从急性和慢性骨髓性白血病和急性淋巴细胞性白血病(ALL)的患者中获得了几种白血病细胞系,但人类白血病细胞的连续培养仍然是一项艰巨的任务。我们在这里描述了从三名ALL患者中新建立的B细胞,T细胞和空细胞白血病细胞系。
        参考ID:1878

      3.S. Hiraki,I。Miyoshi,I。Kubonishi,Matsuda,Y。,中山,T.,Kishimoto,H.,Machida,K.,Masuji,H.和Kimura,I。从人淋巴肉瘤建立T细胞系,Gann,69:115-118,1978。

      • 注意:在患有T细胞性limphosarcoma白血病的患者的骨骼狭窄处,通过连续培养建立了称为TALL-1的白血病T细胞系。TALL-1细胞具有T细胞特性,缺乏Epstein-Barr病毒或其基因组。根据TALL-1细胞的细胞遗传学,形态学和表面特征,认为它们起源于供体的白血病细胞。
        参考编号:1879

      NoteName of CellRegistry No.AnimalTissueDescription
      0-9Page Top
      104C1JCRB9036guinea pigfetal bodyfetal carcass, benzo(a)pyrene transformed, diploid
      16-8JCRB0013mouseantibody-producing hybridomaanti-human erythrocyte, IgM
      19-7JCRB0014mouseantibody-producing hybridomaanti-human erythrocyte, IgM
      293JCRB9068humankidneytransformed embryonal kidney by adenovirus (type5)
      3LLJCRB1348mouselungLewis lung cancer-derived cell line, (C57BL mouse)
      3'-mRLh-2JCRB0431ratliverhepatoma, (Donryu rat)
      3'-mRLN-30JCRB0421ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
      3'-mRLN-31JCRB0422ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
      3T3 L1JCRB9014mouseembryofibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
      3T3-L1IFO50416mouseembryofibroblast, 3T3-Swiss derivative, adipocyte differentiation, (Swiss albino mouse)
      3T3-Swiss albinoIFO50417mouseembryofibroblast, contact inhibited, (Swiss albino mouse)
      3T3-Swiss albinoJCRB9019mouseembryofibroblast, contact inhibited, (Swiss albino mouse)
      3T6-Swiss albinoJCRB9059mouseembryofibroblast, collagen-secreting, (Swiss albino mouse)
      3Y1-B Clone 1-6JCRB0734ratembryofibroblast, whole embryo, (Fischer 344 rat)
      4-2DJCRB0084mouseantibody-producing hybridomaanti-primase complexed with DNA polymerase alpha
      4-8HJCRB0083mouseantibody-producing hybridomaanti-DNA polymerase alpha, IgG1
      4G12 hybridomaIFO50090mouse x humanantibody-producing hybridoma4G12 antibody, preferentially reacting with lung carcinoma-associated antigen
      5RP7IFO50277ratembryofibroblast transformed by c-Ha-ras oncogene
      6-23 clone 6IFO50270ratthyroidmedullary thyroid carcinoma, neurotensin and calcitonin-producing, (WAG/RIJ rat)
      77N1IFO50280ratkidneytransformant of NRK cells by avian sarcoma virus B77, (Osbone-Mendel rat)
      7D4JCRB9092mouse x ratantibody-producing hybridomaanti-murine IL-2 receptors (rat antibody)
      8305CJCRB0824humanthyroidthyroid anaplastic carcinoma, undifferentiated
      8505CJCRB0826humanthyroidthyroid carcinoma, undifferentiated
      9-15cJCRB1181mousebone marrowmesenchymal cell line
      APage Top
      A1IFO50519mouseneuralderives from p53-deficient mouse brain, used for preparation of conditioned medium for MG5 cells
      A-172JCRB0228humanneuralglioblastoma
      A2058IFO50276humanmelanomamalignant melanoma, metastasis to lymph node
      A2B5 clone 105IFO50284mouseantibody-producing hybridomaA2B5 antibody, recognizing a glycolipid expressed in neural tissue
      A3/KAWJCRB0101humanhemo-lymphocyticlymphoma, malignant
      A31-1-1JCRB1356mouseembryofibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
      A31-714 C4IFO50021mouseembryofibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
      A4/FukJCRB0097humanhemo-lymphocyticlymphoma, malignant, B-cell, non-Hodgkin's, IgM kappa-producing
      A-431IFO50411humanepidermoid carcinomaepidermoid carcinoma, high expression of EGF receptor
      A-431JCRB0004humanepidermoid carcinomaepidermoid carcinoma, high expression of EGF-receptor
      A-431JCRB9009humanepidermoid carcinomaepidermoid carcinoma, high expression of EGF-receptor
      A549IFO50153humanlung (cancer)adenocarcinoma
      A549JCRB0076humanlung (cancer)adenocarcinoma
      A9JCRB0211mouseskinskin fibroblast, 8-azaguanine-resistant, (C3H mouse)
      A9(0439)-1JCRB0732human chromosome-introducedhuman chromosomal hybridcontains human chromosome Xpter>Xq26::3p12>3pter
      A9(2621)-4JCRB0730human chromosome-introducedhuman chromosomal hybridcontains human chromosome 12pter>12q24::Xq22>Xqter
      A9(3552)-2JCRB0731human chromosome-introducedhuman chromosomal hybridcontains human chromosome 11pter>11q23::Xq26>Xqter
      A9(3884)-1JCRB0729human chromosome-introducedhuman chromosomal hybridcontains human chromosome 16pter>16q24::Xq26>Xqter
      A9(7151)-3JCRB0728human chromosome-introducedhuman chromosomal hybridcontains human chromosome 17pter>17q11::Xq11>Xqter
      A9(An4)-2JCRB0727human chromosome-introducedhuman chromosomal hybridcontains human chromosome # 1
      A9(Bsr10)JCRB2210human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #10
      A9(BsrX)JCRB2223human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome X
      *8)A9(Hygro13)JCRB2213human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #13
      *8)A9(Hygro14)JCRB2214human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #14
      *8)A9(Hygro21)JCRB2221human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #21
      *8)A9(Hygro22)JCRB2222human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #22
      A9(Neo1)JCRB2201human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 1
      A9(neo11)JCRB2211human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #11
      A9(Neo12)JCRB2212human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #12
      A9(Neo15)JCRB2215human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #15
      A9(Neo16)JCRB2216human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #16
      *8)A9(Neo17)JCRB2217human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #17
      A9(Neo18)JCRB2218human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #18
      A9(Neo19)JCRB2219human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #19
      A9(Neo2)JCRB2202human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 2
      A9(Neo20)JCRB2220human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome #20
      A9(Neo3)JCRB2203human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 3
      A9(Neo4)JCRB2204human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 4
      A9(Neo5)JCRB2205human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 5
      A9(Neo6)JCRB2206human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 6
      A9(Neo7)JCRB2207human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 7
      A9(Neo8)JCRB2208human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 8
      A9(NTI8)-2JCRB0726human chromosome-introducedhuman chromosomal hybridcontains human chromosome # 7
      ABC-1JCRB0815humanlung (cancer)adenocarcinoma
      Ac2FJCRB0408ratlivernormal liver, diploid, (Donryu rat)
      Ac2F(DT)JCRB0416ratliverAc2F-derived, 3'-methyl-4-dimethylaminoazobenzene transformed, (Donryu rat)
      Ac2F(ST)JCRB0417ratliverAc2F-derived, spontaneously transformed, (Donryu rat)
      Ad12-3Y1-Z19JCRB0737ratembryo3Y1 derivative, Ad12-transformed, (Fischer rat)
      AH601(JTC27)JCRB0132.1ratlivertransplantable ascites hepatoma, (Donryu rat)
      AH601.P3(JTC27)JCRB0132.2ratlivertransplantable ascites hepatoma, serum-free, (Donryu rat)
      AH601.P3(JTC27)JCRB0132.3ratlivertransplantable ascites hepatoma, serum-free, direct deposition by original developer. (Donryu rat)
      AH66tcJCRB0411ratliverascites hepatoma, (Donryu rat)
      AH70BtcJCRB0412ratliverascites hepatoma, (Donryu rat)
      AH-7974.P3JCRB0714.1ratliverascites hepatoma, JTC-16 (AH-7974) derivative, serum-free, deposited by original developer, (Donryu rat)
      AIGJCRB1105hamster, Chineselunganchorage-independent mutant of CHL
      Alexander cellsIFO50069humanliver, gallbladderhepatoma, HBs antigen-positive
      AM-38IFO50492humanneuralglioblastoma, GFAP and S-100-positive, ACNU(a cancer chemotherapy drug)-sensitive
      AP-16IFO50424mouseneuralastrocyte-progenitor cell line, (C3H/He mouse)
      AR-EcoScreenJCRB1328hamster, Chineseovaryandrogen receptor-luciferase reporter gene introduced CHO for reporter assay of androgen (MTA to developer is required)
      ARLJ301-3JCRB0248ratliverliver epithelial cell, (F344/DuCrj rat)
      ASF-4-1IFO50418humanskinskin, normal diploid fibroblast
      ASF-4-2IFO50419humanskinskin, normal diploid fibroblast
      ASH-3JCRB1073humanthyroidthyroid anaplastic carcinoma
      *2)AT(L)5KYJCRB0331humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line, ataxia telangiectasia
      *2)AT(L)6KYJCRB0332humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line, ataxia telangiectasia
      *2)AT(L)7KYJCRB0333humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line, ataxia telangiectasia
      *2)AT1OSJCRB0308humanskinataxia telangiectasia, fibroblast
      *2)AT2KYJCRB0316humanskinataxia telangiectasia, fibroblast
      AtT-20JCRB9098mousepituitarypituitary tumor, ACTH producing, (LAF1 mouse)
      AZ-521JCRB0061humanstomachoriginally established as gastric cancer-derived cell line, but is revealed to be the derivative of duodenum carcinoma cell line HuTu 80
      BPage Top
      B-1JCRB0243mousetestisLeydig cell tumor, estrogen-dependent, (BALB/c mouse)
      B104JCRB0117humanhemo-lymphocyticlymphoma, malignant B lymphoma
      *1)B104-R3JCRB0117.1humanhemo-lymphocyticlymphoma, malignant B lymphoma, anti-IgM antibody resistant B104
      B16 melanomaJCRB0202mousemelanomamelanoma, skin, melanin pigment production (but large portion of cells is amelanotic)., (C57BL/6 mouse)
      B2-17IFO50361humanneuralastrocytoma, thymidine kinase-deficient mutant of U251 MG cells
      B8/3JCRB0238mousehemo-lymphocyticerythroleukemia
      B82JCRB0212mouseskinskin fibroblast, bromodeoxyuridine-resistant
      B95-8JCRB9123cotten-top tamarinhemo-lymphocyticEBV transformed, release EBV infectious to primates
      BALB/3T3 A31-1-1JCRB0601mouseembryofibroblast, contact inhibited, (BALB/c mouse)
      BALB/3T3 clone A31JCRB9005mouseembryofibroblast, contact inhibited, (BALB/c mouse)
      Balb/3T3-A31-1-1IFO50070mouseembryofibroblast, subclone of Balb/3T3-A31, (BALB/c mouse)
      Balb/c 3T3 A31-1-13IFO50299mouseembryofibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
      Balb/c 3T3 A31-I-1IFO50298mouseembryofibroblast, subclone of Balb/3T3 A31, (BALB/c mouse)
      BALB-MCJCRB0233.0mousemammarymammary cancer, (BALB/cHe mouse)
      BALB-MC.D3JCRB0233.1mousemammarymammary cancer, (BALB/cHe mouse)
      BALB-MC.E12JCRB0233.2mousemammarymammary cancer, (BALB/cHe mouse)
      BALL-1JCRB0071humanhemo-lymphocyticleukemia, acute lymphoblastoid
      BCE C/D-1bJCRB9129bovinecorneanormal corneal epithelial cell, production of extracellular matrix proteins
      BCL1 Clone CW13.20JCRB9117mousehemo-lymphocyticleukemia, B cell, (BALB/c mouse)
      *2)BCNS1KOJCRB0324humanskinbasal cell nevus syndrome, fibroblasts
      BeckerIFO50289humanneuralastrocytoma, GFAP-negative
      BeWoJCRB9111humanplacentachorio carcinoma, trophoblastic cell line
      Bhas 42JCRB0149mouseembryoH-ras transfected BALB 3T3 A31-1-1, (BALB/c mouse)
      BHK-21(C-13)JCRB9020hamster, Syriankidneykidney, subclone of BHK-21
      BOKUIFO50323humanuterine cervixcervical squamous cell carcinoma
      BRL-3AJCRB0025ratliverMSA (somatomedin-like) protein producing, (Buffalo rat)
      BRL-3AJCRB9114ratliverMSA (somatomedin-like) protein producing, (Buffalo rat)
      *2)BS2CHJCRB0317humanskinBloom's syndrome, fibroblast
      BS2CHTERTJCRB1061humanskinBloom's syndrome, fibroblast, immortalized by hTERT
      BS-C-1IFO50413monkey, African greenkidneysuitable host for transfection experiments of SV40 vectors
      *1)BS-C-1JCRB9011monkey, African greenkidneykidney
      BS-C-1JCRB9126monkey, African greenkidneysuitable host for transfection experiments of SV40 vectors
      BSL2KAJCRB1042humanhemo-lymphocyticEBV transformed B lymphoblastoid cell line from Bloom's syndrome patient
      BW5147.G.1.4.OUA-R.1JCRB9002mousehemo-lymphocyticlymphoma, T cell lymphoma, (AKR/J mouse)
      CPage Top
      C32TGJCRB0227humanmelanomaskin amelanotic melanoma, 6-thioguanine-resistant
      *1)C3H/10T1/2 clone 8JCRB0602mouseembryofibroblast, contact inhibited, (C3H mouse)(Now not available. Please use JCRB0003.)
      C3H/10T1/2 clone 8JCRB9080mouseembryofibroblast, contact inhibited, (C3H mouse)
      C3H/10T1/2-clone 8JCRB0003mouseembryofibroblast, contact inhibited, (C3H mouse)
      C3H/10T1/2-clone8IFO50415mouseembryofibroblast, contact inhibited, (C3H mouse)
      C3H/MCA clone 15IFO50042mouseembryo3-methylcholanthrene-transformed C3H/10T1/2, (C3H mouse)
      C6IFO50110ratneuralglial tumor, GFAP-positive
      C6JCRB9096ratneuralglial tumor, GFAP-positive
      C6/36IFO50010mosquitohatched larvaeuseful for replication of flavivirus
      C6-SF2IFO50425ratneuralC6 subline adapted to serum-free medium
      Ca SkiIFO50007humanuterine cervixcervical epidermoid cancer
      Ca9-22JCRB0625humanoralsquamous carcinoma, gingiva
      Caki-1JCRB0801humankidneyrenal clear cell carcinoma
      CaR-1JCRB0207humanrectumadenocarcinoma
      *1)CCD 841 CoNIFO50482humancolonestablished from normal colonic tissue, epithelial-like, (distribution finished)
      CCD-14BrJCRB9101humanlungbronchus, diploid
      CCD-33CoIFO50483humancolonestablished from normal colon, fibroblast, (the lot in cellbank does not grow)
      CCK-81JCRB0208humancolonadenocarcinoma
      CCRF S-180 IIJCRB9089mousesarcomaS-180 sarcoma derivative
      CCRF-CEMIFO50412humanhemo-lymphocyticleukemia, acute T lymphoblastic
      CCRF-CEMJCRB0033humanhemo-lymphocyticleukemia, acute T lymphoblastic
      CCRF-CEMJCRB9023humanhemo-lymphocyticleukemia, acute T lymphoblastic
      CCRF-HSB2JCRB0031humanhemo-lymphocyticleukemia, acute T lymphoblastic
      CCRF-SBIFO50026humanhemo-lymphocyticleukemia, acute B lymphoblastic
      CCRF-SBJCRB0032humanhemo-lymphocyticleukemia, acute B lymphoblastic
      Ch 1 EsJCRB9037goatesophagusesophagus
      Chang LiverIFO50016humanHeLa-contaminantoriginally established from liver, HeLa-contaminated
      Chang LiverJCRB9066humanHeLa-contaminantoriginally established from liver, HeLa-contaminated
      CHL/IUJCRB0030hamster, Chineselungnormal
      *8)CHO(His9)JCRB2209human chromosome-introducedhuman monochromosomal hybrid panelcontains human chromosome # 9
      CHO(pMAM-HSluc)JCRB0136.2hamster, ChineseovarypMAM-HSluc transfected CHO-K1, HSP 70B gene promoter and luciferase reporter gene introduced
      CHO(pMAM-luc)JCRB0136.1hamster, ChineseovarypMAM-luc transfected CHO-K1, luciferase activated by dexamethasone
      CHO/HGPRTJCRB0218hamster, ChineseovaryHPRT-deficient CHO cell line
      CHO-K1IFO50414hamster, Chineseovarysubclone of CHO (Chainese hamster ovary) cells
      CHO-K1JCRB9018hamster, Chineseovarysubclone of CHO (Chainese hamster ovary) cells
      CKT-1IFO50003bovinekidneyuseful to assay bovine adenovirus 3
      CKT-1JCRB0008bovinekidneyuseful to assay bovine adenovirus 3
      CMK-11-5IFO50430humanhemo-lymphocyticleukemia, acute megakaryoblastic
      CMK-86IFO50428humanhemo-lymphocyticleukemia, acute megakaryoblastic
      CoCM-1JCRB0257humancolonadenocarcinoma
      COLO201JCRB0226humancolonadenocarcinoma
      COLO320 DMJCRB0225humancolonadenocarcinoma
      COS-1JCRB9082monkey, African greenkidneySV40 transformed African green monkey kidney
      COS-7IFO50068monkey, African greenkidneytransformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
      COS-7JCRB9127monkey, African greenkidneytransformant of CV-1 cells by origin-defective SV-40, SV-40 large T antigen-expressing
      *1)CPAIFO50272bovinevascular systempulmonary artery normal endothelial cell
      CPAJCRB9025bovinevascular systempulmonary artery normal endothelial cell
      CPAEJCRB9022bovinevascular systempulmonary artery normal endothelial cell
      CPT-K5JCRB1067humanhemo-lymphocyticleukemia, acute lymphoblastic, camptothecin-resistant mutant of RPMI8402
      CRFKJCRB9035catkidneykidney, BVD antigen negative
      cs-17-25JCRB1102hamster, Chineselungcold-sensitive anchorage-independent growth mutant of CHL
      cs-19-36JCRB1103hamster, Chineselungcold-sensitive anchorage-independent growth mutant of CHL
      cs-20-5JCRB1104hamster, Chineselungcold-sensitive anchorage-independent growth mutant of CHL
      *2)CS2AWJCRB0310humanskinCockayne's syndrome, fibroblast
      CS2AWTERTJCRB1059humanskinCockayne's syndrome, fibroblast, immortalized by hTERT
      *2)CS2OSJCRB0309humanskinCockayne's syndrome, fibroblast
      CS2OS(SVT)JCRB1056humanskinCockayne's syndrome, fibroblast, immortalized by SV40 large T
      CV-1JCRB9049monkey, African greenkidneykidney, highly susceptible to SV40 infection
      c-WRT-7-LRJCRB0168rathemo-lymphocyticRLV infected myelomonocytic leukemia.
      DPage Top
      *1)D422TJCRB9112humansarcomabenign abdominal desmoid tumor
      DaudiJCRB9071humanhemo-lymphocyticlymphoma, Burkitt's
      DBC1.2IFO50484mouseolfactory epitheliumdark (horizontal) basal cell-like, keratin-positive, (C3H/He mouse)
      DD-762JCRB1077mousemammarymammary tumor, producing MuMTV, (DD/Tbr mouse)
      De GinJCRB9078humanskinosteoporosis, skin
      delta-47JCRB1344humanhemo-lymphocyticmyeloma, secreting IgD
      *1)DempseyJCRB9088humanskinKlinefelter's syndrome, skin
      Detroit 510JCRB9104humanskingalactosemia, skin
      Detroit 525JCRB9102humanskinTurner's syndrome, skin
      *1)Detroit 529JCRB9043humanskinDown's syndrome, skin
      Detroit 532JCRB9044humanskinDown's syndrome, foreskin
      Detroit 539JCRB9045humanskinDown's syndrome, skin
      DIG104.10H.1JCRB1213.3mouseantibody-producing hybridomaanti-digoxin antibody, subclass IgG1(k)
      DIG222.4D.5JCRB1213.2mouseantibody-producing hybridomaanti-digoxin antibody, subclass IgG2b(k)
      DL-40JCRB1337humanhemo-lymphocyticlymphoma, non-Hodikin's, Ki-1-positive
      DLD-1JCRB9094humancolonadenocarcinoma
      dRLa-74 Clone 2JCRB0409ratliverliver adenoma, (Donryu rat)
      dRLh-84JCRB0410ratliverhepatoma, (Donryu rat)
      dRLN-4JCRB0418ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
      dRLN-6JCRB0420ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
      dRLN-9JCRB0419ratliverliver cell line, 3'-methyl-4-dimethylaminoazobenzene induced, (Donryu rat)
      DSPT200JCRB0217hamster, Syrianembryofetus fibroblast transformed cell
      DT40JCRB9130chickenhemo-lymphocyticavian leukosis virus (ALV)-induced lymphomas
      EPage Top
      E1A-3Y1-1JCRB0738ratembryo3Y1 derivative, transformed by E1A of Ad12 virus, (Fischer rat)
      *1)EB-3IFO50028humanhemo-lymphocyticeliminated from catalog (IFO50028 EB-3 revealed to be the same as Daudi cell line)
      EBC-1JCRB0820humanlung (cancer)squamous cell carcinoma
      EBTr (NBL-4)JCRB9038bovinelungembryonic trachea
      *5)ECV304JCRB0744humanvascular systemimmortalized normal endothelium, contamination by T-24/EJ1 was suspected.
      EGV-4TJCRB0229ratlungimmortal cell line from MNNG-transformed tracheal epithelial cells
      Ehrlich ascitesJCRB9090mouseascitesEhrlich-Lettre ascites carcinoma
      EHSIFO50268mousesarcomachondrosarcoma, secreting basement membrane matrix, (ST/Eh mouse)
      EJ-1JCRB0710humanbladderbladder carcinoma, contamination by T24 cells has been suspected
      Ex-3LLJCRB1349mouselungLewis lung cancer-derived. Enhanced lung metastasis ability. (C57BL mouse)
      FPage Top
      F119JCRB1324mouseantibody-producing hybridomaanti-CD307 (IRTA2/FcRH5/FCRL5), IgG2b
      F2408IFO50015ratembryofibroblast-like, (Fischer rat)
      F2408 EBNA2 cl-14JCRB0143.5ratembryoEBNA2-transfected, (Fischer rat)
      F2408 EBNA2 cl-16JCRB0143.2ratembryoEBNA2-transfected, (Fischer rat)
      F2408 EBNA2 cl-18JCRB0143.3ratembryoEBNA2-transfected, (Fischer rat)
      F2408 EBNA2 cl-23JCRB0143.6ratembryoEBNA2-transfected, (Fischer rat)
      F2408 EBNA2 cl-24JCRB0143.4ratembryoEBNA2-transfected, (Fischer rat)
      F2408 EBNA2 cl-28JCRB0143.7ratembryoEBNA2-transfected, (Fischer rat)
      F2408 EBNA2 cl-9JCRB0143.1ratembryoEBNA2-transfected, (Fischer rat)
      F2408 pZipNeoJCRB0143.0ratembryopZipNeo-transfected, control for F2408 EBNA2 clones, (Fischer rat)
      F2408-B812IFO50099ratembryoHGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
      F2408-B993IFO50100ratembryoHGPRT(-), TS for transformation by Moloney MSV, (Fischer rat)
      F2408-No.20IFO50101ratembryothymidine kinase-deficient F2408 cell line, (Fischer rat)
      F2408-No.3IFO50098ratembryoHGPRT-deficient F2408 cell line, (Fischer rat)
      F2408-No.7IFO50102ratembryoHGPRT-deficient F2408 cell line, (Fischer rat)
      F25JCRB1323mouseantibody-producing hybridomaanti-CD307 (IRTA2/FcRH5/FCRL5), IgG2a
      F56JCRB1189mouseantibody-producing hybridomaanti-CD307 (IRTA2/FcRH5/FCRL5), IgG1
      F9JCRB0721mouseteratomateratocarcinoma, differentiation-inducible, (129/Sv mouse)
      F9-41JCRB0001mouseteratomateratocarcinoma, differentiation-inducible, (129/Sv mouse)
      *2)FA18JTOJCRB0315humanskinFanconi's anemia, fibroblast
      *2)FA9JTOJCRB0314humanskinFanconi's anemia, fibroblast
      FA9JTOTERTJCRB1060humanskinFanconi's anemia, fibroblast, immortalized by hTERT
      FAA-HTC1JCRB0249ratliverhepatocellular carcinoma, 2-acetylaminofluorene induced, (F344/DuCrj rat)
      FBHEIFO50154bovinevascular systemheart normal endothelial cell, FGF-dependent for survival
      FF101JCRB1040ratliverhepatoma, 3'-methyl-4-dimethylaminoazobenzene-induced, serum-free, (Donryu rat)
      FHs 74 IntJCRB9076humanintestinefetal small intestine, normal, (not intestinal epithelial cell)
      *1)FL*JCRB9016humanHeLa-contaminantoriginally established from amnion, HeLa-contaminated
      FLAM-76JCRB1346humanhemo-lymphocyticmyeloma, IL-6-dependent, growth is very slow
      Flow2000IFO50089humanlungfetal lung, normal diploid fibroblast
      *1)Flow2000JCRB0067humanlungfetal lung, normal diploid fibroblast (not available)
      Flow3000JCRB0068humanneuralnormal fibroblast
      Flow7000IFO50079humanskinskin, normal diploid fibroblast
      FLS3IFO50377mouseliverliver stromal cell line
      FLS5IFO50378mouseliverliver stromal cell line
      FM3AJCRB0701mousemammarymammary carcinoma, spontaneously obtained, (C3H/He mouse)
      FM3A APRT~JCRB0703mousemammarymammary carcinoma, APRT-deficient FM3A, (C3H/He mouse)
      FM3A HPRT~JCRB0702mousemammarymammary carcinoma, HPRT-deficient FM3A , (C3H/He mouse)
      FM3A TK~JCRB0704mousemammarymammary carcinoma, thymidine kinase-deficient FM3A, (C3H/He mouse)
      *2)FPC15JTOJCRB0319humanskinfamilial polyposis coli, fibroblasts
      *2)FPC5JTOJCRB0318humanskinfamilial polyposis coli, fibroblasts
      FRSKJCRB0005ratskinepidermal keratinocyte line from fetal skin
      FS-1IFO50477humanbone marrow stromabone marrow stromal cell from a myelogenous leukemia patient
      FSthy21JCRB0719mousethymidylate defectivecomplete defective strain of thymidylate synthase, (C3H mouse)
      FU97JCRB1074humanstomachadenocarcinoma, poorly differentiated, AFP producing
      GPage Top
      G-292 clone A141B1IFO50107humansarcomaosteosarcoma
      G-361IFO50009humanmelanomamalignant melanoma, skin
      G-361JCRB9074humanmelanomamalignant melanoma, skin
      G-401JCRB9065humankidneyWilms' tumor (embryonal carcinosarcoma of kidney)
      G-402JCRB9070humankidneyrenal leiomyoblastoma
      GAKIFO50321humanmelanomamalignant melanoma at external genitalia, metastasis to lymph node
      GAKJCRB0180humanmelanomamalignant melanoma at external genitalia, metastasis to lymph node
      GB-1IFO50489humanneuralglioma, GFAP, vimentin and fibronectin-positive
      GCH-nu-YSJCRB1201humanuterusgestational uterine choriocarcinoma
      GH1IFO50269ratpituitarypituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
      GH1JCRB9046ratpituitarypituitary tumor, somatotrophin-secreting, (Wistar/Furth rat)
      GH3IFO50105ratpituitarypituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
      GH3JCRB9047ratpituitarypituitary tumor, somatotrophin and prolactin-secreting, (Wistar/Furth rat)
      GHBP116JCRB1226mouseantibody-producing hybridomaanti-human growth hormone receptor antibody-producing, subclass IgG1(k)
      GOTOJCRB0612humanneuralneuroblastoma, adrenal gland
      GOTO.P3JCRB0612.1humanneuralneuroblastoma, adrenal gland, serum-free
      *2)GP-1JCRB1366guinea pighemo-lymphocyticGuinea pig leukocyte line co-infected with HTLV-I and HTLV-II. (This cell line is supplied from National Institute of Biomedical Innovation.)
      GP8JCRB1198mouseskinhuman beta-galactosidase gene introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
      GRSLIFO50111mousehemo-lymphocyticthymic leukemia, (GR/A mouse)
      *2)GS33JTOJCRB0322humanskinGardner's syndrome, fibroblasts, (M)
      *2)GS7OJTOJCRB0323humanskinGardner's syndrome, fibroblasts
      HPage Top
      HARAJCRB1080.0humanlung (cancer)squamous carcinoma, PTHrP producing
      HARA-BJCRB1080.1humanlung (cancer)squamous carcinoma, PTHrP producing, established from nude mouse bone metastasis of HARA cells
      HCA-1JCRB1153humanuterine cervixendocervical adenocarcinoma endocervical adenocarcinoma cell line.
      *4)HCC-56JCRB1037humancolonadenocarcinoma, moderately differentiated
      HCS-2JCRB1203humanuterine cervixcervical squamous cell carcinoma
      HCSC-1JCRB1205humanuterine cervixendocervical small cell carcinoma
      *2)HCT-2JCRB1362hamster, Syrianhemo-lymphocyticHamster spleen lymphocytes transformed by HTLV-I (This cell line is supplied from National Institute of Biomedical Innovation).
      HD-70JCRB1335humanhemo-lymphocyticlymphoma, from Hodgkin's
      HE-1IFO50297humanembryowhole fetus, normal diploid fibroblast
      HEC-1JCRB0042humanuterusendometrial adenocarcinoma
      HEC-108JCRB1123humanuterusendometrial adenocarcinoma
      HEC-116JCRB1124humanuterusendometrial adenocarcinoma
      HEC-151JCRB1122humanuterusendometrial adenocarcinoma
      *5)HEC-155JCRB1127humanuterusendometrial adenocarcinoma, (distribution was suspended)
      HEC-1-AJCRB1117humanuterusendometrial adenocarcinoma
      HEC-1-BJCRB1193humanuterusendometrial adenocarcinoma
      HEC-251JCRB1141humanuterusendometrial adenocarcinoma
      HEC-265JCRB1142humanuterusendometrial adenocarcinoma
      HEC-50BJCRB1145humanuterusendometrial adenocarcinoma
      HEC-59JCRB1120humanuterusendometrial adenocarcinoma
      HEC-6JCRB1118humanuterusendometrial adenocarcinoma
      HEC-88nuJCRB1121humanuterusendometrial adenocarcinoma
      HELJCRB0062humanhemo-lymphocyticleukemia, erythroid
      HeLaJCRB9004humanuterine cervixepitheloid carcinoma
      HeLa 229JCRB9086humanuterine cervixepitheloid carcinoma
      HeLa AGJCRB0213humanuterine cervixepitheloid carcinoma, 8-azaguanine-resistant
      HeLa S3IFO50011humanuterine cervixcervical epithelioid carcinoma
      HeLa S3JCRB9010humanuterine cervixcervical epitheloid carcinoma, adaptable to a suspension culture
      HeLa S3 (sc)JCRB0713humanuterine cervixHeLa derivative, can grow in suspension culture
      HeLa TGJCRB0214humanuterine cervixepitheloid carcinoma, 6-thioguanine-resistant
      HeLa TG CapJCRB0215humanuterine cervixepitheloid carcinoma, 6-thioguanine, chloramphenicol-resistant
      HeLa.P3JCRB0649humanuterine cervixserum free adapted HeLa cell line
      HeLa.P3JCRB0649.1humanuterine cervixserum free adapted HeLa cell line, deposited by original developer
      HeLa.P3(S)JCRB0606humanuterine cervixHeLa cell derived, can grow in a serum-free medium
      HeLa9903JCRB1318humanuterine cervixhERalpha-HeLa-9903, transfected with estrogen receptor-alpha - reporter gene construct. (MTA to developer is required)
      Hep G2JCRB1054humanliver, gallbladderhepatoma
      HEPMJCRB9095humanoralembryonic palatal mesenchyme, limited life span
      HFb16dJCRB1008humanskinnormal fibroblast transfected with HPV16
      HFL1IFO50074humanlungfetal lung, normal diploid fibroblast
      HGH1.1.3JCRB1222.01mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
      HGH1.11.1JCRB1222.08mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
      HGH1.15.3JCRB1222.09mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
      HGH1.17.2JCRB1222.03mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
      HGH1.31.3JCRB1222.12mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
      HGH1.32.4JCRB1222.13mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
      HGH1.35.2JCRB1222.04mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2a(k)
      HGH1.41.1JCRB1222.10mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
      HGH1.46.1JCRB1222.11mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
      HGH1.6.5JCRB1222.02mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
      HGH1.8.1JCRB1222.07mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG2b(k)
      HGH1.9.3JCRB1222.06mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
      HGH2.15.4JCRB1222.16mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(lambda)
      HGH2.4.2JCRB1222.15mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
      HGH2.6.1JCRB1222.05mouseantibody-producing hybridomaanti-human growth hormone antibody, subclass IgG1(k)
      HHJCRB0099bovinevascular systemcarotid artery normal endothelial cell
      HKA-1JCRB1017humanskingiant keratoacanthoma
      HL60JCRB0085humanhemo-lymphocyticleukemia, acute promyelotic, differentiation-inducible
      HL-60IFO50022humanhemo-lymphocyticleukemia, acute promyelocytic, Ability for the differentiation by TPA or DMSO reduced
      HL60(S)JCRB0163humanhemo-lymphocyticleukemia, acute promyelotic
      HL60RGJCRB0006humanhemo-lymphocyticleukemia, acute promyelocytic, HL60-derived, equivalent to IFO50022, Ability for the differentiation by TPA or DMSO reduced
      HLCL-1JCRB0041humanhemo-lymphocyticlymphocyte, peripheral
      HLEJCRB0404humanliver, gallbladderhepatoma, non-differentiated
      HLFJCRB0405humanliver, gallbladderhepatoma, non-differentiated
      HM-1JCRB1208hamster, Syrianhemo-lymphocyticmacrophage line
      HMC-1-8JCRB0166humanmammarybreast cancer, target cell of the T-cell killer clone T(cHMC-1)
      HMY-1JCRB1018humanmelanomamalignant melanoma, sole, melanin production is poor
      HO-1-N-1JCRB0831humanoralsquamous carcinoma, buccal mucosa
      HO-1-u-1JCRB0828humanoralsquamous carcinoma, mouth floor
      HOSIFO50106humansarcomaosteosarcoma
      HPSV178-4-3JCRB1314mouseantibody-producing hybridomaHPSV178 antibody, against GPI-anchorless splice variant of prion protein
      HR-3Y1-2JCRB0743ratembryo3Y1 derivative, transformed by v-H-ras cDNA, (Fischer rat)
      hs-103-3JCRB1096hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
      hs-164-2JCRB1097hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
      hs-171-1JCRB1098hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
      hs-172-3JCRB1099hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
      hs-211JCRB1100hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
      HS-22JCRB1215mousebone marrowmesenchymal stem cell line
      hs-222-3JCRB1101hamster, Chineselungheat-sensitive anchorage-independent growth mutant of CHL
      Hs68IFO50350humanskinskin, normal diploid fibroblast
      HSC-1JCRB1015humanskinsquamous carcinoma
      HSC-2JCRB0622humanoralsquamous carcinoma, mouth
      HSC-3JCRB0623humanoralsquamous carcinoma, tongue
      HSC-4JCRB0624humanoralsquamous carcinoma, tongue
      HSC-5JCRB1016humanskinsquamous carcinoma
      HSC-FJCRB1164monkey, Cynomolgushemo-lymphocyticHSV-immortalized T-cell line, susceptible to SIV
      HSGc-C5JCRB1070humanHeLa-contaminantoriginally established from salivary gland, Hela-contaminated, used as a standardization for the heavy particle irradiation.
      HSP-239JCRB1165chimpanzeehemo-lymphocyticperipheral blood lymphocyte line immortalized with Herpesvirus saimiri
      HSP-250JCRB1177chimpanzeehemo-lymphocyticperipheral blood lymphocyte line immortalized with Herpesvirus saimiri
      HSR-5JCRB1211monkey, rhesushemo-lymphocyticperipheral blood lymphocyte line immortalized with Herpesvirus saimiri
      HS-SultanJCRB9062humanhemo-lymphocyticestablished as plasmacytoma, but revealed as derivative of Jiyoye cell line (Burkitt's lymphoma)
      HT100JCRB0221hamster, Syrianlunglung, new born
      HT-1080IFO50354humansarcomafibrosarcoma, acetabulum
      HT-1080JCRB9113humansarcomafibrosarcoma, acetabulum
      HTC/C3JCRB0164humanthyroidthyroid carcinoma
      HuCCT1JCRB0425humanliver, gallbladderbile duct carcinoma
      *8)huH-1JCRB0199humanliver, gallbladderhepatoma, HBs antigen-positive, HBc(-), HBe(-).
      HuH28JCRB0426humanliver, gallbladderbile duct carcinoma
      HUH-6 Clone 5JCRB0401humanliver, gallbladderhepatoblastoma, well differentiated
      HuH-7JCRB0403humanliver, gallbladderhepatoma, differentiated
      *1)Human Mucosal cellsJCRB9116humancoloncolon
      HuO-3N1JCRB0413humansarcomaosteosarcoma, ilium
      HuO9JCRB0427humansarcomaosteosarcoma
      HuO9N2JCRB0428humansarcomaosteosarcoma
      HUV-EC-CIFO50271humanvascular systemnormal endothelial cell, umbilical cord
      IPage Top
      I-10JCRB9097mousetestisLeydig cell testicular tumor (BALB/cJ mouse)
      I51TJCRB1225mouseskindeficient human beta-gal introduced fibroblast (background, C57BL/6 beta-galactosidase KO mouse-derived SV cells)
      IAR-20JCRB0610ratlivernon-transformed live cell line, (BD-IV rat)
      IHH-4JCRB1079humanthyroidthyroid anaplastic carcinoma, (exhibits the same DNA profile as TMH-1.)
      IM-9IFO50025humanhemo-lymphocyticmyeloma, multiple, B lymphoblastic
      IM-9JCRB0024humanhemo-lymphocyticmyeloma, multiple, B lymphoblastic
      IM95JCRB1075.0humanstomachadenocarcinoma, moderately differentiated
      IM95mJCRB1075.1humanstomachadenocarcinoma, moderately differentiated, an IM95 clone producing higher level of HGF & VEGF
      IMR-32IFO50283humanneuralneuroblastoma
      IMR-32JCRB9050humanneuralneuroblastoma
      *4)IMR-90JCRB0516humanlungfetal lung, normal diploid fibroblast
      IMR-90JCRB9054humanlungfetal lung, normal diploid fibroblast
      IMR-90-40JCRB0519humanlungfetal lung, normal diploid fibroblast, PDL=about 40
      *3)IMR-90-50JCRB0520humanlungfetal lung, normal diploid fibroblast, PDL=about 50
      Indian MuntjacJCRB9100Indian Muntjakskinused for chromosomal study
      IT-26R21IFO50078ratthymusT cell differentiation factor producing, (Wistar rat)
      IT-45R1IFO50076ratthymusT cell differentiation factor producing, (Wistar rat)
      IT-45R91IFO50077ratthymusthymic fibroblast, (Wistar rat)
      IT-79MTNC3IFO50248mousethymusthymic nurse cell, (BALB/c mouse)
      ITO-IIJCRB0613humantestistesticular tumor, (embryonal tumor)
      JPage Top
      J-111IFO50005humanHeLa-contaminantoriginally established from acute monocytic leukemia, HeLa-contaminated
      J-111JCRB0073humanHeLa-contaminantoriginally established from acute monocytic leukemia, HeLa-contaminated
      J774.1JCRB0018mousehemo-lymphocyticmonocyte-macrophage, IL-1-producing, (BALB/c mouse)
      J774A.1JCRB9108mousehemo-lymphocyticmonocyte-macrophage, (BALB/c mouse)
      *6)JHH-1JCRB1062humanliver, gallbladderhepatoma
      *6)JHH-2JCRB1028humanliver, gallbladderhepatoma
      *6)JHH-4JCRB0435humanliver, gallbladderhepatoma
      *6)JHH-5JCRB1029humanliver, gallbladderhepatoma
      *6)JHH-6JCRB1030humanliver, gallbladderhepatoma
      *6)JHH-7JCRB1031humanliver, gallbladderhepatoma, HBV-integration
      JKT-beta-delJCRB0147humanhemo-lymphocyticleukemia, T-cell, Jurkat cell clone with a lack of surface expression of T-cell receptor alpha/beta/CD3 complex
      JTC-11JCRB0424mouseascitesEhrlich ascites
      JTC-16 P3JCRB0714ratliverascites hepatoma, JTC-16 derivative, serum-free, (Donryu rat)
      JTC19JCRB0608ratlunglung, (JAR-1 rat)
      KPage Top
      K562JCRB0019humanhemo-lymphocyticleukemia, chronic myelogenous, differentiation-inducible
      K562/ADMJCRB1002humanhemo-lymphocyticleukemia, chronic myelogenous, adriamycin resistant derivative of K562
      KAI3IFO50518humanhemo-lymphocyticEBV-infected NK-like cell line, IL-2 dependent
      KALS-1IFO50434humanneuralglioma, GFAP, vimentin and CD13-positive
      Kasumi-1JCRB1003humanhemo-lymphocyticleukemia, acute myeloid
      Kasumi-3JCRB1004humanhemo-lymphocyticleukemia, acute myeloperoxidase-negative
      Kasumi-6JCRB1024humanhemo-lymphocyticleukemia, acute myeloid
      KATOIIIJCRB0611humanstomachsignet ring cell carcinoma
      KBJCRB9027humanHeLa-contaminantoriginally established from oral epidermoid carcinoma, HeLa-contaminated
      KCL-22JCRB1317humanhemo-lymphocyticleukemia, chronic myelocytic, Ph1-positive
      KDJCRB9103humanoralfibroblast, lip
      KG-1JCRB0065humanhemo-lymphocyticleukemia, acute myeloblastic
      KG-1JCRB9051humanhemo-lymphocyticleukemia, acute myelogenous
      KG-1-CJCRB0236humanneuralmixed glioma, GFAP-negative, S-100-positive
      KHM-10BJCRB0165humanhemo-lymphocyticlymphoma, Burkitt's, ALL-L3 cell line with a 13q34 abnormality, constitutive c-myc, max expression
      KHM-1BJCRB0133humanhemo-lymphocyticmyeloma, multiple, with hyperamylasemia.
      KHM-3SJCRB0138humanlung (cancer)small cell carcinoma, HTLV-1gene integration
      KHM-5MJCRB0148humanthyroidthyroid carcinoma, undifferentiated, IL-8 producing
      KHYG-1JCRB0156humanhemo-lymphocyticleukemia, NK cell-like, IL-2 dependent
      Ki-JKJCRB1065humanhemo-lymphocyticlymphoma, anaplastic giant cell, Ki-1(CD30)-positive
      KINGS-1IFO50435humanneuralastrocytoma, anaplastic, GFAP, S-100, vimentin, CD13 and HNK-1-positive
      KMBC-2JCRB1148humanbladderurinary bladder carcinoma
      KMH-2JCRB1066humanthyroidthyroid anaplastic carcinoma
      KML-1JCRB1347humanhemo-lymphocyticlymphoma, non-Hodgkins
      KMLS-1JCRB0200humansarcomaliposarcoma
      KMM-1JCRB1180humanhemo-lymphocyticmyeloma
      KMPC-3JCRB1150humankidneycell line derived from renal pelvis
      KMRC-1JCRB1010humankidneyrenal clear cell carcinoma
      KMRC-2JCRB1011humankidneyrenal clear cell carcinoma
      KMRC-20JCRB1071humankidneyrenal cancer
      KMRC-3JCRB1012humankidneyrenal clear cell carcinoma (growth is very slow)
      *4)KMRC-5JCRB1007humankidneyrenal clear cell carcinoma
      KMRM-M1JCRB1014humankidneyrenal carcinoma
      KMS-11JCRB1179humanhemo-lymphocyticmyeloma, multiple, IgG kappa-secreting, EBNA(-)
      KMS-12-BMJCRB0429humanhemo-lymphocyticmyeloma, late stage of B-cell differentiation
      KMS-12-PEJCRB0430humanhemo-lymphocyticmyeloma, late stage of B-cell differentiation
      KMS-20JCRB1196humanhemo-lymphocyticmyeloma
      KMS-21BMJCRB1185humanhemo-lymphocyticmyeloma
      KMS-26JCRB1187humanhemo-lymphocyticmyeloma
      KMS-27JCRB1188humanhemo-lymphocyticmyeloma
      KMS-28BMJCRB1192humanhemo-lymphocyticmyeloma
      KMS-28PEJCRB1191humanhemo-lymphocyticmyeloma
      KMS-34JCRB1195humanhemo-lymphocyticmyeloma
      KMS-6JCRB0432humanembryofibroblast, normal diploid
      KMST-6JCRB0433humanembryofibroblast, immortalized by 60Co irradiation, derivative of KMS-6
      *1)KMST-6/TJCRB0434humanembryofibroblast, immortalized after extensive passages, derivative of KMS-6
      KNS-42IFO50356humanneuralglioma, GFAP-positive, S-100 and NSE-negative
      KNS-60IFO50357humanneuralglioma, GFAP, S-100 and NSE-negative
      KNS-62IFO50358humanlung (cancer)bronchial squamous carcinoma, metastasis to brain
      KNS-81IFO50359humanneuralglioma, GFAP and S-100-positive, NSE-negative
      KNS-81-FDIFO50444humanneuralglioma, derivative of KNS-81 adapted to serum-free medium
      *1)KNS-89IFO50360humanneuralgliosarcoma, GFAP and NSE-positive, S-100-negative (contamination by U-251 MG has been suspected, excluded from catalogue.)
      *5)KO51JCRB0122humanhemo-lymphocyticleukemia, acute myeloblastic, contamination of K562 has been suspected.
      KO52JCRB0123humanhemo-lymphocyticleukemia, acute myeloblastic
      KONJCRB0194humanoralsquamous carcinoma, mouth, ras P21 expression
      KOSC-2 cl3-43JCRB0126.1humanoralsquamous carcinoma, stage III, oral floor
      *5)KOSC-3JCRB0127humanoralsquamous carcinoma, stage III, lower gingiva, contamination by Ca9-22 was suspected.
      *5)KP-1NJCRB0177.0humanpancreaspancreatic cancer, adenocarcinoma (distribution is suspended)
      *5)KP-1NLJCRB0177.1humanpancreaspancreatic cancer, adenocarcinoma, highly metastatic to liver in nude mice (distribution is suspended)
      KP-2JCRB0181humanpancreaspancreatic ductal cell carcinoma, moderately differentiated tubular adenocarcinoma
      KP-3JCRB0178.0humanpancreaspancreatic cancer, adenosquamous carcinoma
      KP-3LJCRB0178.1humanpancreaspancreatic cancer, adenosquamous carcinoma, highly metastatic to liver in nude mice
      KP-4JCRB0182humanpancreaspacnreatic ductal cell carcinoma, secreting PTHrP
      KP-N-RT-BM-1IFO50432humanneuralneuroblastoma, from bone marrow, neuronal and Schwannian differentiation
      KP-N-SI9sIFO50433humanneuralneuroblastoma, from lymph node, smooth muscle marker-expressing
      KP-N-YNIFO50431humanneuralneuroblastoma, from lymph node, smooth muscle marker-expressing
      KS-1IFO50436humanneuralglioblastoma
      KT-5IFO50161mouseneuralastrocyte line, GFAP-positive, (C3H/He mouse)
      KU812IFO50363humanhemo-lymphocyticleukemia, chronic myeloid
      KU812JCRB0104humanhemo-lymphocyticleukemia, chronic myeloid
      KU812EJCRB0104.1humanhemo-lymphocyticleukemia, chronic myeloid
      KU812FJCRB0104.2humanhemo-lymphocyticleukemia, chronic myeloid
      KUM10JCRB1176mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
      KUM3JCRB1134mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
      KUM4JCRB1135mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
      KUM5JCRB1178mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
      KUM6JCRB1202mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
      KUM7JCRB1204mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
      KUM9JCRB1139mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
      KURAMOCHIJCRB0098humanovaryundifferentiated carcinoma, ascites
      KUSA-A1JCRB1119mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
      KUSA-H1JCRB1129mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
      KUSA-OJCRB1132mousebone marrowosteoblastic cell line, mesenchymal stem cell like, (C3H/He mouse)
      KY821JCRB0105humanhemo-lymphocyticleukemia, acute myeloid
      KY821A3JCRB0105.1humanhemo-lymphocyticleukemia, acute myeloid, subclone of KY821
      KYM-1JCRB0627humansarcomarhabdomyosarcoma, neck
      *6)KYSE110JCRB1064humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6)KYSE140JCRB1063humanesophagussquamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6)KYSE150JCRB1095humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6)KYSE170JCRB1082humanesophagussquamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6)KYSE180JCRB1083humanesophagussquamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6)KYSE220JCRB1086humanesophagussquamous carcinoma, moderately differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6)KYSE270JCRB1087humanesophagussquamous carcinoma, well differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6)KYSE30JCRB0188humanesophagussquamous carcinoma, well-differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6)KYSE50JCRB0189humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      *6)KYSE70JCRB0190humanesophagussquamous carcinoma, poorly differentiated, (Japan domestic use only, company users are requested to conclude MTA with originator before order)
      LPage Top
      L alphaJCRB0125mouseskinL cell line introduced with poliovirus receptor protein alpha gene, thymidine kinase defective
      L cl 1DJCRB0722mouseskinfibroblast, thymidine kinase-deficient, (C3H mouse)
      L.P3JCRB0648mouseskinserum-free adapted L929 cell line
      L.P3(S)JCRB0605mouseskinL cell derived, can grow in a serum-free medium, (C3H mouse)
      L1210JCRB9026mousehemo-lymphocyticleukemia, lymphocytic, (DBA/2 mouse)
      L-2JCRB9053ratlungadult lung
      L2CIFO50210guinea pighemo-lymphocyticleukemic cell, maintainable only by transplantation
      L5178YJCRB0709mousehemo-lymphocyticlymphoma, methylcholanthrene induced, (DBA/2 mouse)
      L5178Y TK+/-3.7.2cJCRB0709.1mousehemo-lymphocyticL5178Y derivative, thymidine kinase +/- heterozygotic line
      L5178Y ts2JCRB0723mousehemo-lymphocyticL5178Y derivative, abnormal cell division at non-permissive temperature
      L5178Y ts39JCRB0724mousehemo-lymphocyticL5178Y derivative, micronucleation at non-permissive temperature
      L6IFO50364ratmuscular systemskeletal muscle myoblast
      L6JCRB9081ratmuscular systemskeletal muscle myoblast
      L6TGJCRB0209ratmuscular systemskeletal muscle myoblast, 6-thioguanine-resistant
      L6TG CapJCRB0210ratmuscular systemskeletal muscle myoblast, 6-thioguanine, chloramphencol-resistant

      文档下载: W 导出为JCRB细胞库 JCRB0086.doc文档

      本文来自投稿,不代表本人立场,如若转载,请注明出处:http://www.iamyjet.com/article/6190.html

      (function(){ var src = (document.location.protocol == "http:") ? "http://js.passport.qihucdn.com/11.0.1.js?1d7dde81dc0903e04d3ac0b9599444f6":"https://jspassport.ssl.qhimg.com/11.0.1.js?1d7dde81dc0903e04d3ac0b9599444f6"; document.write('<\/mip-script>'); })(); (function(){ var bp = document.createElement('script'); var curProtocol = window.location.protocol.split(':')[0]; if (curProtocol === 'https') { bp.src = 'https://zz.bdstatic.com/linksubmit/push.js'; } else { bp.src = 'http://push.zhanzhang.baidu.com/push.js'; } var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(bp, s); })();